Fingerprint
Dive into the research topics of 'Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically